{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1116.580",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "CancerLinQ Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-06-03"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2019-03-19"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.580",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1116.580"
    }
  ],
  "version" : "20190319",
  "name" : "TrastuzumabAdministeredWithin12MonthsOfDiagnosis",
  "title" : "Trastuzumab administered within 12 months of diagnosis",
  "status" : "retired",
  "experimental" : false,
  "date" : "2019-03-19T01:00:22-04:00",
  "publisher" : "CancerLinQ Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "concept" : [
          {
            "code" : "G9835",
            "display" : "Trastuzumab administered within 12 months of diagnosis"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:9e410414-bcd7-45f1-8980-7351a100e150",
    "timestamp" : "2024-06-14T11:32:40-04:00",
    "total" : 0
  }
}
